Syndax Pharmaceuticals, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2005-01-01
- Employees
- 184
- Market Cap
- -
- Website
- http://www.syndax.com
Syndax's Revumenib Shows Positive Phase II Results in AML
Syndax Pharmaceuticals announced positive top-line results from the pivotal Phase II portion of the Augment-101 study, evaluating revumenib in acute myeloid leukemia (AML).
© Copyright 2025. All Rights Reserved by MedPath